Cecilia Qvist

Cecilia Qvist, listed as board member, has filed trades across 2 companies (mainly through Finansinspektionen), most often in Embracer Group AB and Apotea AB (publ). Over a trading history stretching from 23 September 2025 to 28 September 2026, the count stands at 3 filings.

The open-market record is one-sided, with 3 purchases worth €29k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2026 alone, the filings show 2 purchases and no sales.

A typical purchase (the median) is worth €1,936. Scaled by market value, the purchases weigh a median 0.0001% of market cap (sample: 3 purchases). 2 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster.

Most recently, on 28 September 2026, the filings show an open-market purchase worth €26k in Embracer Group AB. Most trades are made public on the day they happen. The regulation allows three business days to notify a trade (MAR article 19). Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.